Coverage of key data relating to the science of inflammatory diseases and new developing therapeutic options that target immune-mediated signalling pathways presented at key congresses and reviewed for your information.
November 14th–19th
Washington, DC
Our review and coverage of ACR 2024 highlights the most relevant data on RA, PsA, and axSpA and developing therapeutic options, with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
June 12th–15th
Vienna
Our review and coverage of EULAR 2024 highlights the most relevant data on RA, PsA, and axSpA and developing therapeutic options, with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
Nov 10th–15th
San Diego
Our review and coverage of ACR 2023 highlights the most relevant data on RA, PsA, and axSpA, and developing therapeutic options with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
May 31-June 3rd
Milan
Our review and coverage of EULAR 2023 highlights the most relevant data on RA, PsA, and axSpA, and developing therapeutic options with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
December 05th-09th
Hong Kong
Our review and coverage of APLAR 2022 highlighting the most relevant data on cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways, with our brochures highlighting the key posters and oral presentations ahead of the congress.
View Materials